发明公开
EP1100801A2 UTILISATION DE DERIVES DE LA CYSTEINE POUR PREPARER UN MEDICAMENT DESTINE A TRAITER LES PATHOLOGIES QUI RESULTENT DE LA FORMATION DE LA PROTEINE G HET 有权
半胱氨酸衍生物用于生产旨在疾病的治疗FORTH GOING FROM工作蛋白G HET甲产品应用

UTILISATION DE DERIVES DE LA CYSTEINE POUR PREPARER UN MEDICAMENT DESTINE A TRAITER LES PATHOLOGIES QUI RESULTENT DE LA FORMATION DE LA PROTEINE G HET
摘要:
The invention concerns the use of cysteine derivatives for preparing a medicine for treating diseases resulting from the formation of heterotrimeric G protein. Said diseases include in particular diseases related to biological functions or the following disorders: smell, taste, light perception, neurotransmission, neurodegeneration, functioning of endocrine and exocrine glands, autocrine and paracrine regulation, blood pressure, embryogenesis, benign cell proliferation, oncogenesis, viral infection, immunological functions, diabetes, obesity, benign and malign proliferative diseases. Said cystein derivatives comprise in particular: bis-1,1'-[7-(2-amino-1-oxo-3-thiopropyl)-8-(cyclohexylmethyl)-2-(2-methoxyphenyl)-5,6,7,8-tetrahydroimidazol[1,2a]pyrazine (I) disulphide; and bis-1,1'-7- (2-amino- 1-oxo-thiopropyl- (2-(1-naphthyl)-8- (2-methylpropyl)- 5,6,7,8- tetrahydroimidazol [1,2a]pyrazin-7-yl) disulphide (II).
信息查询
0/0